Carl L. Gordon - 04 Oct 2021 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role
Director, 10%+ Owner
Signature
/s/ Jason Meyenburg, attorney-in-fact
Issuer symbol
IRON
Transactions as of
04 Oct 2021
Net transactions value
$0
Form type
4
Filing time
06 Oct 2021, 16:15:32 UTC
Previous filing
17 Jun 2021
Next filing
08 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRON Stock Option (Right to Buy) Award $0 +17,245 $0.000000 17,245 04 Oct 2021 Common Stock 17,245 $3.80 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date.
F2 Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP.